Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
PMID: 105 MarJSNguyenAScherlAWittkeMDoonaMLambCAet al
99%+ purity, independently lab verified
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
N Engl J Med 2021;384:1719-30.ArticlePubMed 31
BPC-157 is frequently prescribed in combination with TB-500 (Thymosin Beta-4 fragment) in regenerative protocols for injury recovery
